ArticleGastroenterology report2025
Appendicitis burden, trends, and inequalities in Europe, 1990-2019: a population-based study.
Article in Gastroenterology report, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Epidemiology of appendicitis in Ecuador, 2004-2024: a national time-series analysis of incidence, trends, geographic variation, and case-fatality rates.Lancet regional health. Americas · 2026Article
- Preservation Versus Routine Removal: Morbidity and Long-Term Outcomes Following Diagnostic Laparoscopy Versus Negative Appendectomy-A Regional Multicentre Observational Cohort Study.World journal of surgery · 2026Observational
- Global, Regional, and National Burden of Acute Abdominal Conditions in Females-Appendicitis, Ectopic Pregnancy, Paralytic Ileus and Intestinal Obstruction, and Urolithiasis, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021 with ARIMA Projections to 2030.International journal of women's health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Appendicitis imposes a substantial healthcare burden globally, yet comprehensive insights into its disease burden in Europe remain limited. This study assesses regional trends, disparities and high-burden countries for appendicitis in Europe. Methods: Data on appendicitis-related incidence, mortality and disability-adjusted life years (DALYs) were extracted from the Global Burden of Disease 2019 study. Joinpoint regression analyzed temporal trends, while health inequality and quadrant analyses identified socio-demographic disparities and priority countries. Results: In 2019, Europe's age-standardized incidence rate (ASIR) for appendicitis was 266.47 per 100,000, exceeding the global average (229.86 per 100,000). However, Europe's age-standardized mortality rate and age-standardized DALY rate were lower than the global averages. From 1990 to 2019, the average annual percentage change (AAPC) for the ASIR was 0.50%, whereas the AAPCs for the age-standardized mortality rate and age-standardized DALY rate were -3.02% and -2.20%, respectively. Finland was the sole exception, showing a reduced ASIR (AAPC: -0.20%). Health inequality analysis revealed that the burden of DALYs disproportionately affected less developed European nations. However, there was a notable improvement over the past three decades. The slope index of inequality decreased from -7.32 DALYs per 100,000 in 1990 to -1.02 DALYs per 100,000 in 2019, and the relative concentration index fell from -11.04 to -2.58 during the same period. Among the 43 countries, Bulgaria and Austria had the highest 2019 DALY burdens. Conclusions: Appendicitis persists as a critical public health challenge in Europe, necessitating targeted resource allocation and policy interventions in high-burden countries to address persistent health inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.